Upper graph depicts95 undiluted vs 10-fold diluted (corrected for dilution) CA 125 determinations in 57 patients; lower table depicts the percent of patients beyond the indicated percent difference between undiluted and diluted (after correction) from 130-225, 226-321, 322-424, and 425-500 were >50 kU/L, the individual patients' serum samples were rerun at a 10-fold dilution.
Within these serum samples, undiluted values <500 kU/L and >130 kUIL were chosen for further examination.
A value of 130 kUIL was used as the lower limit for the study because a 10-fold dilution results in a value of 13 kU/L, the lower limit of linearity.
The stated upper limit of the assay is 500 kUIL. Overall, the study comprised -98 of 2206 (4.44%) samples from 57 of 308 (18.5%) patients over a 22-month period at our institution.
Shown in Fig. 1 are 95 undiluted and diluted determinations done on 57 patients' samples from the present study. Not shown are data on three samples in which a hook effect was seen. Of 57 patients, 36 had only one undiluted and diluted determination; 21 patients had more than one diluted and undiluted determination. Of these 21, 15 had two determinations, 3 had three determinations, 2 had four determinations, and 1 patient had 14 determinations.
As can been seen in Fig. 1 Again, a significant increase in MDA concentration was observed after administration of protamine sulfate (from 1.21 ± 0.11 imol/L to 1.73 ± 0.22 jkmolIL, P <0.02). The effect was not methodological, because addition of protamine sulfate, 1 or 3 units/mL, to each of five samples produced no effect on measured MDA (0.90 ± 0.23 imo1i'L without protamine vs 0.94 ± 0.16 and 0.85 ± 0.24 mo1/L for 1 and 3 units/mL, respectively).
Since oxygen-derived radicals are of clinical significance in vascular and cardiac surgery, many groups study tissue reperfusion variables, including MDA. In all these procedures, protamine sulfate has to be administered. Thus it is important to consider changes in MDA concentration induced by protamine sulfate.
